News

US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
Quality Assurance & Food Safety13h
FDA Updates General Food Labeling Requirements Compliance Program
General Food Labeling Requirements and Labeling-Related Sample Analysis — Domestic and Import” replaces the previous 2010 ...
MPR18h
FDA Removes REMS, Reduces Monitoring Requirements For Breyanzi and Abecma
The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.
FDA expanding COVID vaccine warnings over rare heart side effect
The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...
Cookie Recall Update as FDA Warning Issued to Customers in 15 States
The recall will remain active until the FDA and Carley's Inc. have resolved the labeling issue and ensured that all ...
FDA requires updated warning about rare heart risk with COVID shots
U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...
US FDA to revise label of ADHD medications to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...